HTA212 A Comparative Analysis of the QALY Shortfall and Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Methods As Ways to Account for Disease Severity in Cost-Effectiveness Analyses for Sickle Cell Disease
Abstract
Authors
M Graf J Kleintjens JW Chou M.T. Hasan N Land JR Baumgardner